Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the mavacamten impact on myocardial structure with cardiac magnetic resonance imaging (CMR) in adult participants with symptomatic obstructive hypertrophic car...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06253221 · Cardiomyopathy, Hypertrophic
NCT04418297 · Cardiomyopathy, Hypertrophic Obstructive
NCT03450252 · Cardiomyopathy, Hypertrophic
NCT04905173 · Hypertrophic Cardiomyopathy, Hypertrophic Obstructive Cardiomyopathy, and more
NCT02842242 · Cardiomyopathy, Hypertrophic Obstructive, Left Ventricular Outflow Tract Obstruction
Local Institution - 0087
West Hollywood, California
Local Institution - 0003
Atlanta, Georgia
Local Institution - 0093
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions